CFRXQ — CONTRAFECT Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$5.41m
Annual balance sheet for CONTRAFECT, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 30.5 | 24.2 | 42.5 | 54.3 | 13.7 |
| Net Total Receivables | — | — | — | 4.1 | 2.6 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 31.4 | 30.8 | 46.7 | 62.9 | 17.7 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.08 | 4.14 | 3.72 | 3.29 | 2.87 |
| Other Long Term Assets | |||||
| Total Assets | 32.9 | 35 | 51.1 | 66.8 | 20.7 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Current Liabilities | 5.8 | 10.1 | 6.06 | 12.2 | 20.8 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 27.3 | 19.5 | 38.5 | 17.4 | 32.5 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 5.54 | 15.5 | 12.6 | 49.4 | -11.9 |
| Total Liabilities & Shareholders' Equity | 32.9 | 35 | 51.1 | 66.8 | 20.7 |
| Total Common Shares Outstanding |